Your health care provider will usually file this report, or you can do it yourself. Claims regarding alleged injury or death due to vaccination have a time limit for filing, which may be as short as two years.
Visit the VICP website external icon or call to learn about the program and about filing a claim. Skip directly to site content Skip directly to page options Skip directly to A-Z link. Section Navigation. Facebook Twitter LinkedIn Syndicate. Hepatitis A VIS. Minus Related Pages. VIS in other languages external icon More information about hepatitis A vaccination.
On This Page. Why get vaccinated? Hepatitis A vaccine Talk with your health care provider Risks of a vaccine reaction What if there is a serious problem? Hepatitis A vaccine can prevent hepatitis A. Hepatitis A vaccine. A small, painless lump may also form, but it usually disappears quickly and is not a cause for concern.
Page last reviewed: 11 March Next review due: 11 March Who should have the hepatitis A vaccine People usually advised to have the hepatitis A vaccine include: close contacts of someone with hepatitis A people planning to travel to or live in parts of the world where hepatitis A is widespread , particularly if sanitation and food hygiene are expected to be poor people with any type of long-term liver disease men who have sex with other men people who inject illegal drugs people who may be exposed to hepatitis A through their job — this includes sewage workers, people who work for organisations where levels of personal hygiene may be poor, such as a homeless shelter, and people working with monkeys, apes and gorillas Contact your GP surgery if you think you should have the hepatitis A vaccine or you're not sure whether you need it.
Types of hepatitis A vaccine There are 3 main types of hepatitis A vaccination: a vaccine for hepatitis A only a combined vaccine for hepatitis A and hepatitis B a combined vaccine for hepatitis A and typhoid fever Talk to your GP about which vaccine is most suitable for you.
Additional Immunization Resources. Adult Vaccination. Screening Checklists. Ask the Experts. Shop IAC. CDC Schedules. Standing Orders for Vaccination. Clinic Tools. State Laws and Mandates. Handouts for Patients and Staff. Technically Speaking. Honor Rolls for Patient Safety. Unprotected People Stories. IAC Express. Vaccine Information Statements. View All Materials. Pregnancy and Vaccines. Top Handouts. Topic Index. Vaccine Index. Schedules for Patients.
Language Index. Administering Vaccines. Standing Orders Templates. Adolescent Vaccination. Storage and Handling. Strategies and Policies.
Temperature Logs. Documenting Vaccination. Vaccine Confidence. Healthcare Personnel. A recombinant hepatitis E vaccine was licensed in China in for use in people ages years old. It is recommended for those at high risk of hepatitis E infection. Centers for Disease Control and Prevention.
Atkinson, W. Feigin, R. Textbook of Pediatric Infectious Diseases , 5 th ed. Philadelphia: Saunders, Immunization Action Coalition. Unusual cases of hepatitis B virus transmission. Plotkin, S. Vaccines , 5 th ed. World Health Organization. American physician and researcher Baruch Blumberg, MD, PhD , was interested in how genes could influence susceptibility to disease. He traveled the world collecting and studying blood samples from different populations.
With a new lab technique, he matched a protein found in the blood of an Australian aborigine with an antibody in the blood of a hemophiliac from the United States. He called the protein the "Australia antigen. Blumberg and others were able to connect the presence of the antigen with hepatitis B infection. Later they related HBV infection to liver cancer.
The Australia antigen circulates in the blood of a previously infected person not only as part of HBV, but also as a small, independent particle. The discovery of the Australia antigen had an important effect on the study of hepatitis B, in large part because HBV cannot be cultivated in the lab.
The Australia antigen could, therefore, serve as a model for the virus as a whole. Moreover, the Australia antigen provided a source for antigen for the vaccine. This hepatitis B vaccine was the first human vaccine produced by recombinant DNA methods. Researchers inserted the code for the antigen into yeast cells, which produced more of the surface protein. The yeast-derived surface protein produced immunity to the hepatitis B virus. Article Menu [ ]. Vaccine Science [ ]. Biological Weapons, Bioterrorism, and Vaccines.
Cancer Vaccines and Immunotherapy. Careers in Vaccine Research. Ebola Virus Disease and Ebola Vaccines. Human Cell Strains in Vaccine Development. Identifying Pathogens and Transmission Vectors.
0コメント